Quarterly report [Sections 13 or 15(d)]

NET LOSS PER SHARE

v3.25.1
NET LOSS PER SHARE
3 Months Ended
Mar. 31, 2025
NET LOSS PER SHARE  
NET INCOME (LOSS) PER SHARE

12.

NET LOSS PER SHARE

Basic net earnings per share applicable to common stockholders is calculated by dividing net earnings applicable to common shareholders by the weighted average shares outstanding during the period, without consideration for common share equivalents. Diluted net earnings per share applicable to common shareholders is calculated by adjusting the weighted average shares outstanding for the dilutive effect of common share equivalents outstanding for the period, determined using the treasury-stock method and the if-converted method. For purposes of the calculation of dilutive net loss per share applicable to common shareholders, stock options, and warrants are considered to be common stock equivalents but are excluded from the calculation of diluted net loss per share applicable to common shareholders, as their effect would be anti-dilutive; therefore, basic and diluted net loss per share applicable to common shareholders were the same for all periods presented.

As of March 31, 2025, 2,162,013 outstanding Pre-Funded Warrants to purchase common shares for little to no consideration were included in the basic and diluted net loss per share calculation. The following table sets forth the computation of basic and diluted net loss per share attributable to common shareholders:

Three Months Ended March 31, 

2025

    

2024

Numerator:

Net loss

$

(7,347,903)

$

(3,635,088)

Denominator:

 

  

 

  

Weighted-average shares outstanding used in computing net loss per share attributable to common shareholders, basic and diluted

 

34,851,203

 

19,533,976

Net loss per share attributable to common shareholders, basic and diluted

$

(0.21)

$

(0.19)

The following outstanding potentially dilutive Common Shares equivalents were excluded from the computation of diluted net loss per share for the periods presented because including them would have been antidilutive:

Three Months Ended

March 31, 

    

2025

    

2024

Options issued and outstanding under stock option plan

 

3,565,859

 

1,152,597

Warrants

 

54,979,373

 

12,861,604

Series 2 Convertible Preferred Shares

1,166,667

Deferred Share Units

 

1,061

 

1,061

Total

 

58,546,293

 

15,181,929